Clinical targeting of the TNF and TNFR superfamilies

被引：359

作者：

Croft, Michael ^{[1
]}

Benedict, Chris A. ^{[1
]}

Ware, Carl E. ^{[2
]}

机构：

[1] La Jolla Inst Allergy & Immunol, Div Immune Regulat, La Jolla, CA 92037 USA

[2] Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, Lab Mol Immunol, La Jolla, CA 92037 USA

来源：

NATURE REVIEWS DRUG DISCOVERY | 2013年 / 12卷 / 02期

基金：

美国国家卫生研究院;

关键词：

ANTI-CD40; MONOCLONAL-ANTIBODY; RELAPSED/REFRACTORY MULTIPLE-MYELOMA; SYSTEMIC-LUPUS-ERYTHEMATOSUS; COLLAGEN-INDUCED ARTHRITIS; CELL MATURATION ANTIGEN; B-LYMPHOCYTE STIMULATOR; VERSUS-HOST-DISEASE; CYTOKINE 1A TL1A; DEATH RECEPTOR 5; T-CELL;

D O I：

10.1038/nrd3930

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Inhibitors of tumour necrosis factor (TNF) are among the most successful protein-based drugs (biologics) and have proven to be clinically efficacious at reducing inflammation associated with several autoimmune diseases. As a result, attention is focusing on the therapeutic potential of additional members of the TNF superfamily of structurally related cytokines. Many of these TNF-related cytokines or their cognate receptors are now in preclinical or clinical development as possible targets for modulating inflammatory diseases and cancer as well as other indications. This Review focuses on the biologics that are currently in clinical trials for immune-related diseases and other syndromes, discusses the successes and failures to date as well as the expanding therapeutic potential of modulating the activity of this superfamily of molecules.

引用

页码：147 / 168

页数：22

共 50 条

[1] Clinical targeting of the TNF and TNFR superfamilies
Michael Croft
Chris A. Benedict
Carl F. Ware
Nature Reviews Drug Discovery, 2013, 12 : 147 - 168
[2] Targeting the TNF and TNFR superfamilies in autoimmune disease and cancer
Croft, Michael
Salek-Ardakani, Shahram
Ware, Carl F.
NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (12) : 939 - 961
[3] Targeting TNF/TNFR superfamilies in immune-mediated inflammatory diseases
Veerasubramanian, Praveen Krishna
Wynn, Thomas A.
Quan, Jie
Karlsson, Fridrik J.
JOURNAL OF EXPERIMENTAL MEDICINE, 2024, 221 (11):
[4] Computational analyses of the interactome between TNF and TNFR superfamilies
Dhusia, Kalyani
Su, Zhaoqian
Wu, Yinghao
COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2023, 103
[5] Shining LIGHT on Functional Promiscuity in the TNF and TNFR Superfamilies
Whalen, Daniel M.
Hymowitzt, Sarah G.
STRUCTURE, 2014, 22 (09) : 1221 - 1222
[6] Disease causing mutations in the TNF and TNFR superfamilies: Focus on molecular mechanisms driving disease
Lobito, Adrian A.
Gabriel, Tanit L.
Medema, Jan Paul
Kimberley, Fiona C.
TRENDS IN MOLECULAR MEDICINE, 2011, 17 (09) : 494 - 505
[7] Editorial: Targeting TNF/TNFR signaling pathways
Pan, Liqiang
Chou, James J. J.
Fu, Tianmin
FRONTIERS IN PHARMACOLOGY, 2023, 13
[8] Therapeutic potential of targeting TNF/TNFR family members in asthma
Doherty, Taylor A.
Croft, Michael
IMMUNOTHERAPY, 2011, 3 (08) : 919 - 921
[9] Origin and evolution of TNF and TNF receptor superfamilies
Wiens, Gregory D.
Glenney, Gavin W.
DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2011, 35 (12): : 1324 - 1335
[10] Targeting the TNF-alpha/TNFR interaction with small molecule mimetics
Davis, Jessica M.
Pace, Christopher
Meister, Russell
Perrucci, Rachel
Steele, Christopher
Erin, Culbert
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237

← 1 2 3 4 5 →